Original Source(s)
Related Content
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
FDA Approves New Iohexol Vials
The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.
July 17, 2026
-
2 min
Mavacamten Treatment Associated With Improved Diastolic Function, Remodeling Markers
Real-world follow-up data from 465 patients add to evidence from earlier randomized trials.
June 27, 2026
-
3 min